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Translocation across intestinal epithelial cells is an established pathogenic feature of the zoonotic bacterial species Campylobac-
ter jejuni. The number of C. jejuni virulence factors known to be involved in translocation is limited. In the present study, we
investigated whether sialylation of C. jejuni lipooligosaccharide (LOS) structures, generating human nerve ganglioside mimics,
is important for intestinal epithelial translocation. We here show that C. jejuni isolates expressing ganglioside-like LOS bound
in larger numbers to the Caco-2 intestinal epithelial cells than C. jejuni isolates lacking such structures. Next, we found that gan-
glioside-like LOS facilitated endocytosis of bacteria into Caco-2 cells, as visualized by quantitative microscopy using the early
and late endosomal markers early endosome-associated protein 1 (EEA1), Rab5, and lysosome-associated membrane protein 1
(LAMP-1). This increased endocytosis was associated with larger numbers of surviving and translocating bacteria. Next, we
found that two different intestinal epithelial cell lines (Caco-2 and T84) responded with an elevated secretion of the T-cell at-
tractant CXCL10 to infection by ganglioside-like LOS-expressing C. jejuni isolates. We conclude that C. jejuni translocation
across Caco-2 cells is facilitated by ganglioside-like LOS, which is of clinical relevance since C. jejuni ganglioside-like LOS-ex-
pressing isolates are linked with severe gastroenteritis and bloody stools in C. jejuni-infected patients.
Campylobacter jejuni, a zoonotic Gram-negative bacterialpathogen, is able to enter, survive in, and translocate across
intestinal epithelial cells (22, 27, 42). Such gastroinvasive patho-
gens often employ common eukaryotic cellular pathways such as
endocytosis (7, 22, 33, 42, 43). Endocytosis provides the general
entry portal of eukaryotic cells for uptake of nutrients and for
regulation of membrane-bound receptors and signaling (16). En-
docytosis consists of early and later stages that can be conveniently
distinguished using specific proteinmarkers. The proteinmarkers
frequently used to study the different endocytic stages of intracel-
lular pathogens are early endosome-associated protein 1 (EEA1),
the GTPases Rab5 and Rab7, and lysosome-associated membrane
protein 1 (LAMP-1) (16). EEA1 andRab5 are involved in the early
stages of endocytosis (40) and Rab7 marks later stages (31),
whereas LAMP-1 marks the end stage, when late endosomes are
fused with lysosomes (9, 10). At the final stages of endocytosis,
endolysosomal vesicles, organelles in which large molecules and
even intact bacteria can be degraded, are formed (16, 19, 23).
Factors involved in the escape from the endosomal pathway have
been studied well for intracellular bacteria such as Salmonella en-
terica, Listeria monocytogenes, Mycobacterium tuberculosis, and
Brucella abortus (16). Studies to better define such factors in C.
jejuni have recently been initiated (4).
Currently, for C. jejuni it is considered that the flagellum is the
primary adherence factor that establishes contact between the eu-
karyotic cell membrane and specific bacterial-invasion factors
(22). Proposed invasion factors are capsular polysaccharides,
Peb1 and JlpA, or other still-unknown outer membrane-related
structures (1, 24, 34–36). It is thought that these invasion factors
activate host cell plasmamembrane invaginations at sites whereC.
jejuni bacteria are present. These invaginations may then form an
endosomal compartment that is transported from the apical to the
basolateral surface, enabling C. jejuni translocation across the in-
testinal epithelial barrier (22, 27, 33). The effect of such an en-
trance mechanism on C. jejuni intracellular survival was noted by
Watson and Galan, who showed that C. jejuni isolate 81176 in-
vaded epithelial cells via unique small plasma membrane invagi-
nations called caveolae. This specificmanner of entrance was then
found to contribute to the escape of 81176 from the canonical
endocytic pathway (42). In other words, for this isolate it was
demonstrated that it was able to escape lysosomal degradation,
contributing to its intracellular survival (42). Recently, Buelow
and coworkers showed that intracellular survival of C. jejuni iso-
late NCTC11168 is enhanced by the secreted Cia protein (Cj1450)
that was found to block fusion of lysosomes with the C. jejuni-
containing endosome (4). The studies by Watson and Galan (42)
and Buelow et al. (4) did not show which specific bacterial inva-
sion factor(s) facilitates endocytosis of C. jejuni into epithelial
cells.
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At present, there is increasing evidence that sialylated lipo-
oligosaccharide (LOS) structures expressed on the C. jejuni outer
surface (12) are potential internalization factors (18, 37). Interest-
ingly, sialylated LOS structures are also present on the well-char-
acterized C. jejuni 81176 isolate (17) that is able to induce severe
colitis in humans and monkeys (2, 38). A more recent clinical
study showed that sialylation of C. jejuni LOS structures, which
mimic human peripheral nerve gangliosides (37), was strongly
associated with severe gastroenteritis and bloody stools in C. je-
juni-infected patients (32).Having noted the associations between
expression of ganglioside-like LOS by different C. jejuni isolates
and the induction of severe gastroenteritis and bloody stools in
humans (2, 32), we set out to investigate a potential pathogenic
mechanism that might explain this correlation. We hypothesized
that severe gastroenteritis could be a result of increased numbers
of endocytosed and translocating bacteria in the human intestine.
The present work was therefore designed to explore the effect of
ganglioside-like LOS on C. jejuni endocytosis, intracellular sur-
vival, and translocation across human intestinal epithelial cells.
MATERIALS AND METHODS
Bacterial strains. Thirty-two clinical C. jejuni isolates and the 81176 ref-
erence isolate were used in this study (Table 1). To further analyze the role
of ganglioside-like LOS, we used two previously generated cst-II mu-
tants, GB11cst-II and GB19cst-II, and a cst-II complemented isolate,
GB11cst-II, here named GB11 (C). The cst-II gene encodes a sialyl-
transferase that transfers sialic acid onto LOS structures (6). The specific
protocols for generation of the cst-II mutants and the complemented
GB11 (C) can be found elsewhere (11, 29). Tominimize in vitro passaging,
C. jejuni isolates were recovered from the original glycerol stock by cul-
turing on Butzler agar plates (Becton, Dickinson, Breda, The Nether-
lands). The cst-II mutants were then grown on blood agar plates con-
taining 7% sheep blood (Becton, Dickinson, Breda, The Netherlands)
supplemented with vancomycin (Sigma-Aldrich, Zwijndrecht, The Neth-
erlands) (10 g/ml) and chloramphenicol (Sigma-Aldrich, Zwijndrecht,
The Netherlands) (20 g/ml); erythromycin (Sigma-Aldrich, Zwijn-
drecht, The Netherlands) (0.02 g/ml) was used for selection of GB11
(C). A final passage on commercial Columbia blood agar plates (Becton,
Dickinson, Breda, The Netherlands) for wild types, cst-II mutants, and
GB11 (C) was allowed for optimal vitality and equal growth conditions
before infection assays. All isolates and mutants and the complemented
mutant were incubated at 37°C in an anaerobic jar undermicroaerophilic
conditions using an Anoxomat gas mixer (Mart, Drachten, The Nether-
lands). Bacterial cells were harvested in Hanks balanced salt solution
(HBSS) (Invitrogen, Breda, The Netherlands) at 37°C, and densities were
set using optical density at 600 nm (OD600). The LOS class was deter-
mined by PCR, using protocols previously described (11).
Motility assays.C. jejuni suspensions were prepared to an OD600 of 1.
A semisolid agar plate (Mueller-Hinton [MH] broth plus 0.4% agar) was
inoculated with 1 l of the bacterial suspension by stabbing. Plates were
grown at 37°C under microaerophilic conditions, and the resulting circle
diameters exemplifying bacterial swimming were measured after incuba-
tion for 24 h. The swimming analysis and diameter motility zone mea-
surements were performed three times for wild types and acst-IImutant
strain.
Intestinal epithelial cell lines. Two human intestinal epithelial cell
lines, Caco-2 and T84, were used in this study. Caco-2 is a human colon
carcinoma cell line, and T84 is a transplantable differentiating human
carcinoma cell line; both harbor the characteristic of differentiating when
maintained in culture for extended periods of time (5, 15, 21, 45). Caco-2
and T84 have been used earlier for C. jejuni studies (27, 45). We main-
tained the Caco-2 and T84 cell lines in Dulbecco’s modified Eagle’s me-
dium (DMEM) (Invitrogen, Breda, The Netherlands) supplemented with
10% fetal bovine serum (FBS) (Invitrogen, Breda, The Netherlands) and
1% nonessential amino acids (NEAA) (Invitrogen, Breda, The Nether-
lands). The cells were grown in a 75-cm2 flask (Greiner Bio-one, Alphen
a/d Rijn, The Netherlands) at 37°C and 5% CO2 in a humidified air incu-
bator.
Adhesion to intestinal epithelial cells. Caco-2 cells were grown to
40% to 50% confluence on chamber slides (Greiner Bio-one, Alphen a/d
Rijn, The Netherlands). C. jejuniwas inoculated at a multiplicity of infec-
tion (MOI) of 100. Fifteenminutes after inoculation, theCaco-2 cells were
washed three times with 37°C prewarmed HBSS (Invitrogen) and fixed
with 4% formaldehyde (Sigma-Aldrich, Zwijndrecht, The Netherlands)–
HBSS (Invitrogen) at room temperature for 2 h. Cells were washed three
times with HBSS (Invitrogen) and blocked with 1% fetal bovine serum–
HBSS (block buffer). To visualize C. jejuni, an anti-C. jejuni fluorescein
isothiocyanate (FITC)-labeled antibody (Genway, San Diego, CA) was
diluted 1:100 in block buffer and incubated for 1 h. The Caco-2 cells were
washed three times with HBSS (Invitrogen) and dehydrated for 1 min
TABLE 1 C. jejuni isolates, presence of genes needed for sialic acid
biosynthesis, and ganglioside-like LOS expression
Isolatea
Presence of
LBGESb Ganglioside mimic(s)c
GB1  None
GB3  GM1, GD1a
GB4  None
GB11  GM1, GD1a
GB16  GD1c
GB17  GA1, GM1b, GD1c
GB18  GM1, GD1a
GB19  GD1c
GB22  GM1a, GD1a
GB23  GM2
GB25  GA1, GM1b, GD1c
GB29  None
81176  GM2, GM3
11168  GM1, GM2
R3  None
R33  ND
R37  None
R61  ND
E9141  ND
E9144  ND
E9146  ND
E98-623  None
E98-624  None
E98-706  None
E98-1033  GM1
E98-652  GM1a, GQ1b
E98-682  GM1a, GQ1b
E98-1087  GM1a
R65  ND
R67  ND
R95  GA1
R104  ND
R109  GM1a
a Isolates used to study colocalization of C. jejuni with LysoTracker DND-99, swarming,
and chemokine secretion. GB, Guillain-Barré; R and E, enteritis-associated isolates.
b PCR results, scoring the presence () or absence () of the LOS Biosynthesis Genes
Enabling Sialylation (LBGES).
c Ganglioside-like LOS (GM) detected with mass spectrometry. GA1, ganglioside-like
LOS without sialic acid; None, no ganglioside-like LOS was detected; ND, not
determined. For the other isolates, ganglioside-like LOS structures were determined by
rapid mass spectrometry screening (8) or by antibody probing (652, 682, 1033, 1087,
R95, R109). Note that the presence of LBGES does not always mean ganglioside-like
LOS expression due to frameshift mutations in the LBGES (12).
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with 70% ethanol and another minute with 100% ethanol (Sigma-Al-
drich, Zwijndrecht, The Netherlands). The culture chamber on the slides
was removed, and the slides with Caco-2 cells were air dried. Slides with
Caco-2 cells were mounted with fluorescent mounting medium (Dako,
Carpinteria, CA). A coverslip was placed on top, and slides were analyzed
on an XI51 phase-contrast fluorescence microscope (Olympus, Leiden,
The Netherlands). Photos were taken with an Olympus XM10 color cam-
era at1,000magnification and analyzed for adhesion with the Olympus
software CellFˆ (Olympus). For each isolate, an average of 30 pictures were
taken at randomfields, showing binding ofC. jejuni bacteria to theCaco-2
cells. Experiments were independently repeated three times.
Gentamicin exclusion invasion assay. Epithelial cell invasion by C.
jejuni was determined by growing Caco-2 cells on a cell culture multiwell
plate (Greiner Bio-one, Alphen a/d Rijn, TheNetherlands) (6 wells) into a
monolayer until formation of domes was observed by phase-contrast mi-
croscopy. Formation of domes of the Caco-2 cells is a strong indication of
differentiation (15, 30). The invasion protocol was performed as previ-
ously described (29). Briefly, Caco-2 monolayers with formation of
domes were incubated together with C. jejuni at an MOI of 100 for 4 h at
37°C and 5% CO2. Following the invasion period, cells were washed with
prewarmed DMEM (Invitrogen) and incubated for another 2 h in me-
dium containing gentamicin (Sigma-Aldrich, Zwijndrecht, The Nether-
lands) (480 g/ml) to kill extracellular bacteria. After the gentamicin
treatment, the infected Caco-2 cells were washed three times with HBSS
(Invitrogen) and lysed with 0.1% Triton X-100 (Sigma-Aldrich, Zwijn-
drecht, The Netherlands)–phosphate-buffered saline (PBS) (Invitrogen,
Breda, The Netherlands) for 15 min at room temperature to release the
intracellular bacteria. The number of viable bacteria released from the
Caco-2 cells was assessed after serial (10-fold) dilutions of the lysates on
Columbia blood agar plates (Becton, Dickinson).
Immunofluorescence. Caco-2 cells were grown to 40% to 50% con-
fluence on chamber slides (Greiner Bio-one), andC. jejuniwas inoculated
at anMOI of 100. A series of time course experiments were started, based
on a prior study (42), to detect and confirm that the observed colocaliza-
tion time points were optimal for analysis of colocalization of the endo-
somal primary antibody markers EEA-1 (Biosciences BD, Breda, The
Netherlands), Rab5 (Santa Cruz, CA), Rab7 (Abcam, Cambridge, MA),
and LAMP-1 (Abcam, Cambridge, MA) with intracellular C. jejuni cells.
For EEA-1, the incubation time after inoculation of C. jejuni into the
chambers of the chamber slides was 30min; for Rab5, 40min; for Rab7, 45
min; and for LAMP-1, 2 h. Prior to visualization, Caco-2 cells were
washed three times with 37°C prewarmed HBSS (Invitrogen) and fixed
with 4% formaldehyde (Sigma-Aldrich) in HBSS (Invitrogen) at room
temperature for 2 h. Caco-2 cells were again washed three times with
HBSS (Invitrogen). Afterward, the Caco-2 cells were permeabilized for 20
min with 0.1% HBSS–Triton X-100 solution and background antibody
binding was blocked with block buffer (1% fetal bovine serum, 1%Tween
20, HBSS). Slides were then incubated for 1 h with the respective primary
antibody (for EEA-1, Rab5, Rab7, or LAMP-1) at a 1:100 dilution in block
buffer. The appropriate secondary antibodies from the IgG class (HL),
A594 labeled (Molecular Probes, Bleiswijk, TheNetherlands), providing a
red stain, were selected for EEA1, Rab5, Rab7, and LAMP-1. Further prep-
aration and visualization occurred as described inMaterials andMethods
upon adherence of intestinal epithelial cells. Experiments were indepen-
dently repeated three times. In order to obtain the mean percentage of
colocalization of bacteria, the number ofC. jejuni bacteria that colocalized
with an endosomalmarkerwas divided by the number ofC. jejuni bacteria
that did not colocalize with an endosomalmarker but were instead bound
on a Caco-2 cell and the result was multiplied by 100.
Lysotracker DND-99 staining. To monitor the lysosomal develop-
ment of vacuoles containing intracellular bacteria, we used the protocol
described by the manufacturer (Invitrogen, Breda, The Netherlands) to
test whether theC. jejuni-containing endosomal compartment was acidic.
Briefly, the stock solution was diluted to a final working concentration of
1 mM in DMEM (Invitrogen) containing 10% FBS (Invitrogen) and 1%
NEAA (Invitrogen). Caco-2 cells were preincubated with LysoTracker
DND-99 (Invitrogen) for 30 min under the culture conditions described
above. After preincubation, C. jejuni bacteria were added to a well in the
chamber slide at anMOI of 100. After 2 h of incubation, Caco-2 cells were
washed three timeswith prewarmedHBSS (Invitrogen) at 37°C to remove
excess bacteria and LysoTracker DND-99 (Invitrogen). Fixation and vi-
sualization occurred as described above.
Intracellular survival.To assay intracellular survival, an adapted gen-
tamicin exclusion assay was used as described previously (42). Initially,
the invasion protocol was followed, with the modification that after gen-
tamicin treatment, the medium was replaced with complete DMEM (In-
vitrogen) still containing gentamicin (10g/ml) (Sigma-Aldrich)without
penicillin and streptomycin for overnight incubation. Plating of the infec-
tionmedium showed that no CFUwere present after this treatment. After
overnight incubation, three additional washes with HBSS (Invitrogen)
were performed, after which the invasion protocol for plating was fol-
lowed as previously described (42).
Translocation across differentiated Caco-2 cell monolayers.Caco-2
cells were seeded onto Transwell filters at 4 10 5 cells/filter using 24-well
plates (Costar, Corning Inc. Corning, NY) (5 m pore size, 1.13 cm2).
This pore size was large enough to enable further C. jejuni translocation
after cell passage. TheCaco-2 cells were allowed to differentiate for 19 days
to form tight junctions (14, 15). The formation of tight junctions was
established by transepithelial electric resistance measurements (TEER)
(15). C. jejuni isolates were added at an MOI of 10 at the apical surface of
the polarized Caco-2monolayer on the Transwell filter (Costar Corning).
After 72 h, 100-l samples were taken from the apical and basolateral
surfaces and serial dilutions (1:10) were plated on Columbia blood agar
plates (Becton, Dickinson). Plates were incubated for 24 h at 37°C in an
anaerobic jar under microaerobic conditions using an Anoxomat gas
mixer (Mart). Colonies were counted, and the numbers of CFU per mil-
liliter were calculated.
CXCL8 and CXCL10 measurement. For CXCL8 and CXCL10 mea-
surements, 96-well flat-bottomed plates (Nunc, Roskilde, Denmark)were
coated with 3 ng of rabbit anti-human CXCL8 or CXCL10 (Endogen,
Cambridge, MA) per well. CXCL8 is interleukin-8 (IL-8) and is a neutro-
phil recruiter, and CXCL10, also known as gamma interferon-induced
protein 10 (IP-10) as opposed to IL-10, is a T-cell recruiter. Overnight
culture supernatants from Caco-2 and T84 cells grown to confluence in
6-well plates that had been infected at an MOI of 100 with wild-type
isolates (Table 1) the previous day were diluted 1 to 1 in PBS (Invitrogen)
and supplemented with 0.1% Tween 20 and bovine serum albumin (3
mg/ml). CXCL8 and CXCL10 were detected and quantified against a cal-
ibration line with a biotin-coupled detection antibody (0.5 mg/ml). The
assay was developed with avidin-peroxidase (Gibco-BRL, Breda, The
Netherlands) (500 mg/ml) and TMB (3,3=,5,5=-tetramethylbenzidine;
Sigma) according to the manufacturers’ instructions.
Statistical analysis. Statistical analysis was performed using Instat
software (version 2.05a; GraphPad Software, San Diego, CA). Log trans-
formation was used to equalize variances. Differences between GM and
GM isolates were tested for significance with a nonparametric Mann-
Whitney U test, since column statistics had shown that the Gaussian dis-
tributions were unequal for the isolates. A paired t test was used to test for
significant differences between the wild type and cst-II mutants. For
comparisons of the wild-type GB11, knockout mutant GB11cst-II, and
GB11 (C), an analysis of variance (ANOVA) test was used. A P value 
0.05 indicates statistical significance.
RESULTS
Ganglioside-like LOS expression by cst-II does not affect C. je-
juni swimming behavior. C. jejuni motility is suggested to be of
importance for adherence, invasion, and epithelial translocation
(13, 44). We analyzed whether differences in motility existed be-
tween ganglioside-like LOS-expressing C. jejuni isolates (GM)
and isolates that do not express such mimics (GM). Swimming
C. jejuni Ganglioside Mimics Facilitate Transcytosis
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behavior was compared for 16 (GM) and 12 (GM) isolates in
low-percentage agar culture plates. No significant differences in
swimming were found between these two groups of isolates (P
0.67) (Fig. 1). Knockout mutagenesis of a gene essential for the
generation of ganglioside-like LOS, sialyltransferase cst-II, con-
firmed that motility in low-percentage agar culture plates was not
dependent on the presence or absence of ganglioside-like LOS,
since the wild-type (GM) isolate GB11 and its cst-II mutant,
GB11cst-II (GM), displayed equal swimming diameters, both
with a mean of 11 mm.
Ganglioside-like LOS increases the number of C. jejuni bac-
teria bound to Caco-2 cells. We determined whether C. jejuni
ganglioside-like LOS expression had an effect on binding of bac-
teria to the Caco-2 cells. Microscopic analysis of Caco-2 cells dur-
ing the first 15min of infection revealed that isolate 81176 (GM)
bound more efficiently to the Caco-2 cells than isolate R104
(GM) (Fig. 2). Next, quantitative microscopic analysis showed a
3-fold-increased binding capacity of the GM GB11, GB19, and
81176 isolates to the Caco-2 cells in comparison with the GM
isolates R104, R65, and 9141, which all lack ganglioside-like LOS
(P 0.0001) (Fig. 2A). The effect ofC. jejuni ganglioside-like LOS
expression on binding to the Caco-2 cells was further determined
by using cst-II mutants. Previously, we showed that loss of the
cst-II gene lead to loss of ganglioside-like LOS production (11).
Microscopic analysis revealed that the wild-type isolate GB11
(GM) bound more efficiently to the Caco-2 cells than its cst-II
mutant (GM) (Fig. 2). Quantitative microscopic analysis estab-
lished that the capacity of the GB11cst-II and GB19cst-II mu-
tants to bind the Caco-2 cells was strongly reduced compared to
that of the corresponding wild-type isolates (P  0.0001)
(Fig. 2B). We also found that the cellular binding levels of GB11
(C) were significantly elevated compared to those of the
GB11cst-IImutant but were still lower than those of the original
GB11 wild-type isolate (Fig. 2B), likely because of the absence of
GD1 structures in GB11 (C) (see Fig. S1 in the supplemental ma-
terial). These results show that ganglioside-like LOS contributes
strongly to C. jejuni intestinal epithelial cell binding during the
first 15 min of infection.
Ganglioside-like LOS enhancesC. jejuni endocytosis.To fur-
ther explore the involvement of ganglioside-like LOS during the
early stages of infection, we determined the colocalization of our
isolates with the early endosomalmarkers EEA1 andRab5.Micro-
scopic analysis revealed that isolate 81176 (GM) colocalized in
larger numbers with the early endosomalmarkers EEA1 and Rab5
than isolates R104 andR65 (GM), respectively (Fig. 3 and Fig. 4).
In the time frame used to study EEA1 and Rab5 colocalization
with the C. jejuni isolates, we continued to observe that C. jejuni
ganglioside-like LOS contributed strongly to Caco-2 cell binding
(Fig. 3A and C and 4A and C). Next, all three of GM isolates
81176, GB11, and GB19 showed increased colocalization with the
early endosomal markers EEA1 and Rab5 in comparison to the
GM isolates R104, R65, and 9141 (P 0.0001; Fig. 3B and 4B).
Comparing the wild-type isolates (GB11 and GB19) and the cor-
responding cst-II mutants (GB11cst-II and GB19cst-II) and
GB11 (C) unambiguously established that the observed differ-
FIG 1 Ganglioside-like LOS expression by cst-II does not affect C. jejuni
swimming behavior. The plots show the mean swimming diameters in milli-
meters for 16 GM isolates and 12 GM isolates (three independent experi-
ments). No significant differences in swimmingwere found betweenGM and
GM isolates (P 0.67; Mann-Whitney U test).
FIG 2 Ganglioside-like LOS increases the number of C. jejuni bacteria bound
to the Caco-2 cells. Visualization of C. jejuni bacteria that were bound to the
Caco-2 cells after 15 min of inoculation is shown. C. jejuni was detected using
FITC-labeled (green) antibodies. Red-labeled antibodies detected EEA1 in
Caco-2 cells. White bars indicate numbers of GM bacteria that did bind the
Caco-2 cells; black bars indicate binding by GM bacteria. The differences in
binding between GM isolates GB11, GB19, and 81176 and GM isolates
R104, R65, and 9141 were significant (Mann-Whitney U test; *, P 0.0001).
The differences in cellular binding between wild-type GB11 (GM),
GB11cst-II (GM), and GB11 (C) (GM) (one-way ANOVA; *, P 0.0001)
and GB19 and the GB19cst-IImutant (paired t test; *, P 0.0001) were also
significant.
Louwen et al.
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ences in colocalization with EEA1 and Rab5 were dependent on
ganglioside-like LOS expression by C. jejuni (Fig. 3D and 4D).
Rab7 is not involved in C. jejuni endocytosis. The Rab7 pro-
tein is amarker for later stages of endosomal trafficking (41) but is
not essential for endosome maturation preceding fusion with
lysosomes (3). All GM and GM isolates used in this study were
tested at different time points between 15 min and 2 h postinfec-
tion (hpi) for colocalization with Rab7. We detected a significant
increase in colocalization with Rab7 only for isolate R65 (GM)
after 45 min (results not shown). For the other isolates, no signif-
icant colocalization with Rab7 was observed at any point in time
used in this study. In summary, Rab7 appeared not to be a good
marker to study later stages of endosomal trafficking ofC. jejuni in
the Caco-2 cells.
Ganglioside-like LOS-expressing C. jejuni bacteria colocal-
ize in larger numbers with LAMP-1. We then determined colo-
calization with LAMP-1, a marker associated with the fusion be-
tween late endosomes and lysosomes (39). We observed at 2 hpi
that both the 81176 and R65 isolates colocalized with LAMP-1
(Fig. 5). At 2 hpi, we still found thatC. jejuni ganglioside-like LOS
expression promoted cellular binding during the ongoingC. jejuni
infection of the Caco-2 cells (Fig. 5A and C). We screened all
isolates at 2 hpi and found that the GM GB11, GB19, and 81176
isolates colocalized with LAMP-1 in larger numbers than the
GM R104, R65, and 9141 isolates (Fig. 5B). We also observed
that GM bacteria tended to cluster in large compartments that
colocalized with LAMP-1, a characteristic that was not observed
forGM isolates (Fig. 5). Comparing thewild-type isolates (GB11
FIG 3 C. jejuni bacteria colocalize in enhanced numbers with EEA1 when they express ganglioside-like LOS. Visualization of C. jejuni bacteria that
colocalized with the endosomal marker EEA1 in the Caco-2 cells after 30 min of inoculation is shown. The white arrows indicate examples of colocal-
ization; colocalizing bacteria and EEA1 signals appear yellow in the merged pictures (right). Significant differences in cellular binding and colocalization
with EEA1 were observed (A and B) between GM isolates GB11, GB19, and 81176 and GM isolates R104, R65, and 9141 (Mann-Whitney U test; *,
P 0.0001) and (C and D) between wild-type GB11, GB11cst-II, and GB11 (C) (one-way ANOVA; *, P 0.0001) and GB19 and the GB19cst-IImutant
(paired t test; *, P  0.0001).
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and GB19), the cst-II mutants (GB11cst-II and GB19cst-II),
andGB11 (C) established that the observed differences in colocal-
ization with LAMP-1 were determined by the expression of gan-
glioside-like LOS (Fig. 5D).
C. jejuni-containing vesicles are acidic. We explored the
physical nature of theC. jejuni-containing vesicles that colocalized
with LAMP-1 by using LysoTracker DND-99, a stain specific for
acidic (endo-)lysosomes (28). At 2 hpi, we observed that the 81176
(GM) isolate colocalized in larger numbers with LysoTracker
DND-99 in comparison to isolate R65 (GM) (Fig. 6). To confirm
this observation, we tested the GM GB11, GB19, and 81176 iso-
lates and the GM R104, R65, and 9141 isolates for colocalization
with LysoTracker DND-99. We found that the GM isolates co-
localized in larger numbers with LysoTracker DND-99 than the
GM isolates (P 0.0001) (Fig. 6A). As was observed at 2 hpi for
LAMP-1 staining, LysoTracker DND-99 colocalization also re-
vealed that GM isolates clustered in large intracellular compart-
ments. As for LAMP-1, we were able to establish by using wild-
type isolates (GB11 and GB19),cst-IImutants (GB11cst-II and
GB19cst-II), and GB11 (C) that the observed differences in co-
localization with Lysotracker DND-99 were dependent on C. je-
juni ganglioside-like LOS expression (Fig. 6B).
To investigate if therewas any isolate effect on the acidic nature
of the C. jejuni-containing vacuole, we extended the LysoTracker
DND-99 study with 14 additional C. jejuni isolates (5 GM and 9
GM isolates) (see Fig. S2 in the supplemental material). We es-
FIG 4 C. jejuni bacteria colocalize in enhanced numbers with Rab5 when they express ganglioside-like LOS. Visualization of C. jejuni bacteria that colocalized
with the endosomalmarker Rab5 in the Caco-2 cells after 40min of inoculation is shown. Significant differences in cellular binding and colocalization with Rab5
were observed (A and B) between GM isolates GB11, GB19, and 81176 and GM isolates R104, R65, and 9141 (Mann-Whitney U test; *, P 0.0001) and (C
and D) between wild-type GB11, GB11cst-II, and GB11 (C) (one-way ANOVA; *, P  0.0001) and GB19 and the GB19cst-II mutant (paired t test; *, P 
0.0001).
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tablished that theGM isolates colocalized in larger numberswith
LysoTracker DND-99 than the GM isolates (P  0.0001) (see
Fig. S2 in the supplemental material). These results confirm that
both the GM and GM isolates at 2 hpi were localized in acidic,
presumably destructive endolysosomal vesicles in the Caco-2
cells.
Significant differences in survival and invasion between
GM andGMC. jejuni isolates.Apreviously published adapted
gentamicin killing assay (42) was used to study whether enhanced
cellular endocytosis by GM isolates correlated with increased
intracellular survival. All isolates (GM and GM) showed a 50-
to-100-fold reduction in CFU per milliliter at 24 hpi (Fig. 7A and
B) compared to the initially retrieved numbers for invasion at 4
hpi of Caco-2 cells (Fig. 7C and D). Intracellular survival rates
calculated in percentages revealed no significant differences be-
tween GM and GM isolates; only 1% to 3% of the initially
invadedGM andGM isolates detected at 4 hpi survived after 24
hpi. In contrast, the total number of intracellular recoverable
GM bacteria was significantly higher than the number seen with
the GM isolates (P  0.0001) (Fig. 7A). This finding was con-
firmed using two wild-type isolates, GB11 and GB19 (GM), and
the corresponding cst-II mutants (GM) (Fig. 7B). Comparing
the intracellular survival of GB11 (C) with that of the GB11cst-II
mutant (GM) andGB11wild type (GM) showed restoration of
survival to near-wild-type levels in the survival assays (Fig. 7E).
These assays demonstrated that the more C. jejuni bacteria enter
the Caco-2 cells, themore survive, a process found to be facilitated
by C. jejuni ganglioside-like LOS.
FIG 5 C. jejuni bacteria colocalize in enhanced numbers with LAMP-1 when they express ganglioside-like LOS. Visualization ofC. jejuni bacteria that associated
with the endosomal marker LAMP-1 in the Caco-2 cells after 120min of inoculation is shown. Significant differences in cellular binding and colocalization with
LAMP-1 were observed (A and B) between GM isolates GB11, GB19, and 81176 and GM isolates R104, R65, and 9141 (Mann-Whitney U test; *, P 0.0001)
and (C and D) between wild-type GB11, GB11cst-II, and GB11 (C) (one-way ANOVA; *, P 0.0001) and GB19 and the GB19cst-IImutant (paired t test; *,
P 0.0001).
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C. jejuni translocation across Caco-2 cells is facilitated by
ganglioside-like LOS.At 72 hpi,C. jejuni isolates GB11 andGB19
(GM) had translocated more efficiently across differentiated
Caco-2 cells than the corresponding cst-II mutants (GM),
without disrupting the transepithelial electric resistance (TEER)
(see Fig. S3 in the supplementalmaterial).On average, we sampled
4.9 104 CFU/ml and 4.4 104 CFU/ml translocating bacteria
from the basolateral side for GB11 and GB19 (GM), respectively
(Fig. 8A). For the two corresponding cst-II mutant strains
(GM), 8.6 102 CFU/ml and 4.3 102 bacteria, respectively,
were sampled, representing results that were lower by factors of 50
to 100 (Fig. 8A). Comparing the translocation efficiency of GB11
(C) (GM) with that of the GB11cst-II mutant (GM) and
GB11 wild-type (GM) isolate in translocation assays confirmed
thatC. jejuni ganglioside-like LOS indeed facilitated intestinal ep-
ithelial cell translocation (Fig. 8B). In addition, the total numbers
of bacteria of the C. jejuni wild-type isolates, the corresponding
cst-II mutants, and GB11 (C) that had translocated after 72 hpi
(Fig. 8A and B) correlated well with the numbers of C. jejuni bac-
teria that were recovered for each isolate after completion of the
survival assays (Fig. 7B and E).
Ganglioside-like LOS-expressing C. jejuni bacteria elevate
CXCL10 release from intestinal epithelial cells. Levels of CXCL8
secretion by Caco-2 cells following infection by GM or GM
isolates were not significantly different (Fig. 9A). In contrast,
CXCL10 secretion was induced significantly more upon infection
by isolates expressing ganglioside-like LOS in comparison with
GM isolates (P 0.0001) (Fig. 9B). To confirm the generality of
this finding, a subset of 10 GM and 6 GM isolates was used to
test their capacity to induce secretion of CXCL8 and CXCL10
using a different intestinal epithelial cell line, T84. Using this cell
line established, as for the Caco-2 cells, that the levels of CXCL8
secretion were not significantly different upon infection by GM
or GM isolates, whereas for CXCL10 the secretion was signifi-
cantlymore elevated upon infection byGM isolates compared to
GM isolates (P 0.0047) (Fig. 9C and D).
DISCUSSION
Ganglioside-like LOS expression by C. jejuni has been shown to
correlate with disease complications in humans in different stud-
ies (11, 32, 37), but the pathogenic mechanism(s) behind this
process remains obscure. In the present study, we extended our
previous findings (11, 18, 20) aimed at characterizing the role of
ganglioside-like LOS expression in C. jejuni pathogenesis and in-
duction of disease complications. Some intracellular bacteria have
developedmechanisms to avoid delivery to lysosomes in intestinal
epithelial cells to be able to survive, replicate, and translocate (3,
16). Earlier, it was shown thatC. jejuni isolate 81176 survives in the
FIG 6 C. jejuni-containing vesicles are acidic. Visualization of C. jejuni bacteria that associated with Lysotracker DND-99 in the Caco-2 cells after 120 min of
inoculation is shown. Significant differences in colocalization with Lysotracker DND-99 were observed between (A) GM isolates (GB11, GB19 and 81176) and
GM isolates (R104, R65, and 9141) (Mann-Whitney U test; *, P  0.0001) and (B) wild-type GB11, GB11cst-II, and GB11 (C) (one-way ANOVA; *, P 
0.0001) and GB19 and the GB19cst-IImutant (paired t test; *, P 0.0001).
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intracellular environment by lysosomal escape (42). In this study,
we were able to link ganglioside-like LOS expression with in-
creased endocytosis into and translocation across Caco-2 cells but
not with lysosomal escape.
So far, C. jejuni lysosomal escape has been visualized only with
endosomal protein markers in nonintestinal epithelial cells (4,
42). In our study, using Caco-2 cells we could clearly demonstrate
that GM and GM C. jejuni bacteria are located in an acidic
intracellular compartment with endolysosome characteristics
wherein most C. jejuni bacteria are killed. Our finding that only a
small percentage (1% to 3%) of the C. jejuni bacteria (GM and
GM) survived at 24 hpi suggests that C. jejuni survival in the
Caco-2 cells depends on the number of endocytosed bacteria
rather than on differential intracellular survival of GM versus
GM isolates. A simple explanation for this finding could be that
Caco-2 cells do not have enough “endosomal capacity” to clear all
infecting bacteria. Data showing that C. jejuni bacteria are com-
pletely eradicated by professional phagocytic cells such as macro-
phages (42) give support to this notion.
In the present study, we corroborated with our endosomal
analysis the findings ofHu et al., who observed that less than 4%of
the Caco-2 cells in their study became infected by C. jejuni isolate
81176, depending on the MOI used (22). Next, those authors ob-
served by electron microscopy that the number of internalized C.
jejuni bacteria ranged between 1 and 20 bacteria per infected
Caco-2 cell (22), a variation we also observed for our 81176 isolate
in our colocalization experiments. The low number of infected
Caco-2 cells could forman explanation in the present study for the
large number of GM C. jejuni bacteria bound to the Caco-2 cells
with respect to the MOI used. Earlier, Hu et al. had already spec-
FIG 7 Significant differences in survival and invasion between GM and GMC. jejuni isolates. The bar graphs show survival ofC. jejuni isolates in Caco-2 cells
after 24 h for (A)wild-type isolates only and (B) thewild type andcst-IImutants and invasion capacity after 4 h for (C)wild-type isolates only and (D)wild-type
isolates and cst-IImutants. Survival and intracellular recovery are shown as CFU per milliliter (CFU/ml). Data are shown as the standard errors of the means
of the results of at least three independent experiments. Differences in survival and invasion between GM and GM (Mann-Whitney U test; *, P 0.0001) and
wild types (GM) and cst-IImutants (GM) (paired t test; *, P 0.0039) were significant. (E) Differences in survival between wild-type GB11, GB11cst-II,
and GB11 (C) after 24 h were significant (one-way ANOVA; *, P 0.0001).
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ulated that this low number of infected Caco-2 cells might be
related to the expression of a specific surface receptor, making
some of the Caco-2 cells hypersusceptible for C. jejuni (22).
Our Transwell experiments clearly showed that the differenti-
ated Caco-2 cells are an efficient barrier blocking C. jejuni trans-
location, because after 72 hpi, only a small percentage of the inoc-
ulum used translocated across differentiated Caco-2 monolayers.
In line with previous studies (22, 26, 45), our data also provide
support for a transcytosis-mediated model for C. jejuni transloca-
tion across host epithelia, including apical endocytosis and baso-
lateral exocytosis.
First, in the time line of our translocation assay, we did not
observe any significant change in the TEER, a strong indication
that the tight junctions of the differentiated Caco-2 cells re-
mained intact (15) in the presence of C. jejuni. Second, visual-
ization of the C. jejuni endocytosis process with the endosomal
markers EEA1, Rab5, LAMP-1, and Lysotracker DND-99
showed that C. jejuni bacteria are transported via the cellular
endosomal pathway. Finally, the numbers of intracellular sur-
viving C. jejuni bacteria cultured from dome-forming Caco-2
cell monolayers in a multiwell culture plate corresponded with
the numbers of C. jejuni bacteria translocating across differen-
tiated Caco-2 cells in a Transwell system. Of course, we have to
be careful in comparing such experiments concerning the po-
tential differences in the Caco-2 cell culture methods and dif-
ferentiation status. On the other hand, in our opinion, the fact
that similar numbers for survival and translocation were ob-
served suggests that the mechanism of C. jejuni translocation
across Caco-2 cells is favorable for cellular transcytosis, a pro-
cess we here show to be facilitated by ganglioside-like LOS.
Next, we were able to show that enhanced endocytosis of gan-
glioside-like LOS-expressing C. jejuni bacteria was linked with in-
creased secretion of CXCL10 by intestinal epithelial cells. Our
findings on CXCL10 corroborate a previous study showing that
the intestinal epithelial internalization capacity of the C. jejuni
isolates correlated with the amount of CXCL10 release (25). Fu-
ture in vivo studies are necessary to investigate if this link between
the expression of ganglioside-like LOS, the enhanced internaliza-
tion capacity of C. jejuni, and the amount of CXCL10 secretion is
of clinical relevance.
In our experiments, phase variation could have influenced
ganglioside-like LOS expression. Earlier, interaction studies of
comparisons between C. jejuni and sialic acid binding immu-
noglobulin-like lectins by Heikema et al. established that the
strains, some of which were used in the present study, still
express functional membrane-bound ganglioside-like LOS
(20). Furthermore, mass spectrometry using exactly the same
bacterial glycerol stocks as used in the present study had dem-
onstrated the GM and GM LOS structures of the isolates (8,
12) used in this study. Most importantly, the results obtained
with the wild types, cst-II mutants, and complemented cst-II
mutant show that any effect of phase variation on the study
results has been negligible.
Based on our results, we hypothesize that the effect of C. jejuni
ganglioside-like LOS on cellular endocytosis, increased transloca-
tion, and elevated CXCL10 secretion could form a mechanistic
basis for the severe gastroenteritis phenotype that has been ob-
served in patients infected with GM C. jejuni isolates (32).
We conclude that C. jejuni translocation across intestinal epi-
thelial cells is facilitated by ganglioside-like LOS, as depicted in a
graphical model (Fig. 10), and propose that ganglioside-like LOS
FIG 9 Ganglioside-like LOS-expressing C. jejuni bacteria elevate the CXCL10
release from intestinal epithelial cells. (A) CXCL8 and (B) CXCL10 secretion
from the Caco-2 cells was analyzed after infection with 32 C. jejuni isolates
(Table 1). Scatter plots show themeasurements of the results of 3 independent
experiments. (C)CXCL8 and (D)CXCL10 secretion from the T84 cells. Blocks
represent the GM C. jejuni isolates; triangles represent the GM C. jejuni
isolates. An asterisk (*) indicates a significant difference in released secretion of
the corresponding chemokine from the Caco-2 cells (Mann-Whitney U test;
P 0.0001) or the T84 cells (Mann-Whitney U test; P 0.0047). For both of
the untreated cell lines (Caco-2 and T84), CXCL8 secretion and CXCL10 se-
cretion in the culture supernatants were nondetectable.FIG 8 C. jejuni translocation across Caco-2 cells is facilitated by ganglioside-
like LOS. (A) Translocation of C. jejuni isolates across Caco-2 cells was mea-
sured as CFU per milliliter after 72 h, using wild-type isolates GB11 and GB19
(GM) in comparison with their cst-II mutants, GB11cst-II and
GB19cst-II (GM), respectively. Differences in translocation between the
wild type (GM) and thecst-IImutant (GM) were significant (paired t test;
*, P  0.005). (B) Translocation efficiency restored to near-wild-type levels
was observed forGB11 (C). Data are shown as the standard errors of themeans
of the results of at least three independent experiments performed in duplicate.
Differences in translocation between GB11, GB11cst-II, and GB11 (C) were
significant (one-way ANOVA; *, P 0.0001).
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belongs to the repertoire of virulence factors that are used by a
subset of C. jejuni bacteria to interact with the host epithelium.
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